Daniela Ricci

Daniela Ricci

Auto-generated profile, based on publicly available information

Daniela Ricci

Paediatric Neurology Unit Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Early Human Development
Verified
Journal Article
Closed access
DRDaniela Ricci
Daniela Ricci
SAShirley Anker
Shirley Anker
FCFrances Cowan
Frances Cowan
MPMarika Pane
Marika Pane
FGFrancesca Gallini
Francesca Gallini
EMEugenio Mercuri
Eugenio Mercuri

10 September 2019 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
PDF file
DRDaniela Ricci
Daniela Ricci
DMDiego Martinelli
Diego Martinelli
GFGloria Ferrantini
Gloria Ferrantini
SLSimona Lucibello
Simona Lucibello
MGMluigia Gambardella
Mluigia Gambardella
EMEugenio Mercuri
Eugenio Mercuri
Cobalamin C (cblC) defect is the most common inherited disorder of cobalamin metabolism. Developmental delay, behavioral problems, and maculopathy are common, but they have not been systematically investigated. The aim of this study was to define early neurodevelopment in cblC patients and the possible contribution of different factors, such as mode of diagnosis, age at diagnosis, presence of brain lesions and epilepsy. Children up to the age of 4 years with a visual acuity ≥1/10 were evaluated using the Griffiths' Mental Development Scales. Eighteen children were enrolled (age range 12‐48 months). Four were diagnosed by newborn screening (NBS); in the others mean age at diagnosis was 3.5 months (range 0.3‐18 months). Eight had seizures: three in the first year, and five after the second year of life. Fourteen had brain lesions on magnetic resonance imaging (MRI). Neurovisual assessment evidenced low visual acuity (<3/10) in 4/18. NBS diagnosed patients had higher general and subquotients neurodevelopmental scores, normal brain MRI, and no epilepsy. The others showed a progressive reduction of the developmental quotient with age and language impairment, which was evident after 24 months of age. Our findings showed a progressive neurodevelopmental deterioration and a specific fall in language development after 24 months in cblC defect. The presence of brain lesions and epilepsy was associated with a worst neurodevelopmental outcome. NBS, avoiding major disease‐related events and allowing an earlier treatment initiation, appeared to have a protective effect on the development of brain lesions and to promote a more favorable neurodevelopment.

1 September 2000 in Neuropediatrics
Verified
Journal Article
Closed access
PDF file
TRT. Randò
T. Randò
DRD. Ricci
D. Ricci
EMEugenio Mercuri
Eugenio Mercuri
MFM. F. Frisone
M. F. Frisone
RLR. Luciano
R. Luciano
FGF. Guzzetta
F. Guzzetta
We report on periodic lateralized epileptiform discharges (PLEDs) on EEG in two infants with neonatal convulsions. In both neonates, the EEG abnormalities were seen soon after the onset of seizures, at a time when cranial ultrasound scans were thought to be normal. Subsequent Magnetic Resonance Imaging scans demonstrated cerebral infarction in both patients. In one case, the localisation of the lesion on MRI was concordant with that of the EEG abnormalities, as usually observed in adults with focal lesions. The other infant showed similar EEG abnormalities, but her MRI showed a localised lesion in the basal ganglia, which has also been reported to be involved in the genesis of these abnormalities.

29 January 2024 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
Domenico RomeoDomenico Romeo
Domenico Romeo
CVChiara Velli
Chiara Velli
FSFrancesca Sini
Francesca Sini
EPElisa Pede
Elisa Pede
GCGraziamaria Cicala
Graziamaria Cicala
EMEugenio Mercuri
Eugenio Mercuri
Aim: To develop a short version of the original Hammersmith Infant Neurological Examination (HINE) to be used as a screening tool (Brief‐HINE) and to establish if the short examination maintains good accuracy and predictive power for detecting infants with cerebral palsy (CP).Method: Eleven items were selected from the original HINE (‘visual response’; ‘trunk posture’; ‘movement quantity’; ‘movement quality’; ‘scarf sign’; ‘hip adductor angles’; ‘popliteal angle’; ‘pull to sit’; ‘lateral tilting’; ‘forward parachute reaction’; ‘tendon reflexes’) identifying those items previously found to be more predictive of CP in both low‐ and high‐risk infants. In order to establish the sensitivity of the new module, the selected items were applied to existing data, previously obtained using the full HINE at 3, 6, 9, and 12 months, in 228 infants with typical development at 2 years and in 82 infants who developed CP.Results: Brief‐HINE scores showed good sensitivity and specificity, at each age of assessment, for detecting infants with CP. At 3 months, a score of less than 22 was associated with CP with a sensitivity of 0.88 and a specificity of 0.92; at 6, 9, and 12 months, the cut‐off scores were less than 25 (sensitivity 0.93; specificity 0.87), less than 27 (sensitivity 0.95; specificity 0.81), and less than 27 (sensitivity 1; specificity 0.86) respectively. The presence of more than one warning sign, or items that are not optimal for the age of assessment, imply the need for a full examination reassessment.Interpretation: These findings support the validity of the Brief‐HINE as a routine screening method and the possibility of its use in clinical practice.

23 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
FGFrancesca Gallini
Francesca Gallini
MPMaria Sofia Pelosi
Maria Sofia Pelosi
DRDomenico Umberto De Rose
Domenico Umberto De Rose
MCMaria Coppola
Maria Coppola
Simonetta CostaSimonetta Costa
Simonetta Costa
GVGiovanni Vento
Giovanni Vento
Background: Few studies in the literature have analyzed the long-term neurodevelopmental outcomes of the administration of a multicomponent versus a soybean-based lipid emulsion (LE) in preterm infants receiving parenteral nutrition (PN). A recent randomized controlled trial conducted in our unit provided evidence of better growth in head circumference during the hospital stay in those who received a multicomponent LE. Methods: This is a 24 month follow-up study of preterm infants, previously enrolled in a randomized trial, who received a multicomponent LE (SMOFlipid®) or a standard soybean-based one (Intralipid®). We evaluated neurodevelopmental outcomes at 24 months of corrected age (CA) in the two groups. Results: Ninety-three children were followed up to the age of 24 months CA. Due to the peculiar time frame of the SARS-CoV-2 pandemic, neurodevelopmental outcomes were evaluated only in 77 children: 37 in the SMOFlipid® group and 40 in the Intralipid® group. No differences in major disability rates or in Griffith’s evaluation were found between the two groups. Conclusions: In our population study, the administration of a multicomponent LE containing fish oil, compared to a soybean-based LE, had no significant effects on neurodevelopmental outcomes in preterm infants at 24 months CA.

29 August 2014 in Early Human Development
Verified
Journal Article
Closed access
CBClaudia Brogna
Claudia Brogna
PRPaola De Rose
Paola De Rose
SSSerena Sivo
Serena Sivo
VLValentina Laganà
Valentina Laganà
AGAlessandra Graziano
Alessandra Graziano
DRDaniela Ricci
Daniela Ricci